Please login to the form below

Not currently logged in
Email:
Password:

Clinigen appoints Shaun Chilton as COO of services division

Former KnowledgePoint360 Group president and MD will head both Keats Healthcare and Clinigen GAP

Clinigen, the UK-based specialty pharmaceutical and pharma services provider, has appointed Shaun Chilton to the newly-created role of chief operating officer of the group's services division.

Chilton joins from healthcare information supplier KnowledgePoint360 Group, where he was both president and managing director.

In his new role he will head both Clinigen's clinical trial supply business Keats Healthcare and Clinigen GAP, a specialist provider of early- and late-lifecycle prescription drugs, streamlining the two businesses.

Keats Healthcare, which was acquired by Clinigen in 2010, is currently being rebranded as Clinigen CTS.

Commenting on the appointment, Chilton said: “Keats Healthcare and Clinigen GAP are already successful businesses providing standalone services, but they are highly complementary and synergies between the two companies make their combination into a services division compelling.”

He joins the company from KnowledgePoint360 Group, a supplier of healthcare information, and prior to that held positions in sales and marketing at both Pfizer and Sanofi.

Peter George, CEO of Clinigen, said: “Shaun has a strong track record of building and leading high-performance sales and operational teams; driving commercial growth from international businesses; developing highly effective strategies, including major restructurings; and executing new strategies to deliver business goals, improve profitability and meet challenging targets.”

23rd January 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics